TY - JOUR
T1 - Comparative effectiveness of telemedicine strategies on type 2 diabetes management
T2 - A systematic review and network meta-analysis
AU - Lee, Shaun Wen Huey
AU - Chan, Carina Ka Yee
AU - Chua, Siew Siang
AU - Chaiyakunapruk, Nathorn
N1 - Funding Information:
We would like to thank Dr Nai Ming Lai (Taylor’s University) for critically reviewing the manuscript for content, Jun Yang Lee, En Kiat Liew, Bee Kim Tan and Leanne Ooi for their assistance in this study. The publication is based on a clinical research funded by the Ministry of Science, Technology and Innovation, MOSTI e-Science Fund (06-02-10-SF0238). The funder had no role in the study design, data collection, data analysis and interpretation, writing of the report, or the decision to submit the article for publication.
Publisher Copyright:
© 2017 The Author(s).
Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2017/10/4
Y1 - 2017/10/4
N2 - The effects of telemedicine strategies on the management of diabetes is not clear. This study aimed to investigate the impact of different telemedicine strategies on glycaemic control management of type 2 diabetes patients. A search was performed in 6 databases from inception until September 2016 for randomized controlled studies that examined the use of telemedicine in adults with type 2 diabetes. Studies were independently extracted and classified according to the following telemedicine strategies: teleeducation, telemonitoring, telecase-management, telementoring and teleconsultation. Traditional and network meta-analysis were performed to estimate the relative treatment effects. A total of 107 studies involving 20,501 participants were included. Over a median of 6 months follow-up, telemedicine reduced haemoglobin A1c (HbA1c) by a mean of 0.43% (95% CI: -0.64% to -0.21%). Network meta-analysis showed that all telemedicine strategies were effective in reducing HbA1c significantly compared to usual care except for telecase-management and telementoring, with mean difference ranging from 0.37% and 0.71%. Ranking indicated that teleconsultation was the most effective telemedicine strategy, followed by telecase-management plus telemonitoring, and finally teleeducation plus telecase-management. The review indicates that most telemedicine strategies can be useful, either as an adjunct or to replace usual care, leading to clinically meaningful reduction in HbA1c.
AB - The effects of telemedicine strategies on the management of diabetes is not clear. This study aimed to investigate the impact of different telemedicine strategies on glycaemic control management of type 2 diabetes patients. A search was performed in 6 databases from inception until September 2016 for randomized controlled studies that examined the use of telemedicine in adults with type 2 diabetes. Studies were independently extracted and classified according to the following telemedicine strategies: teleeducation, telemonitoring, telecase-management, telementoring and teleconsultation. Traditional and network meta-analysis were performed to estimate the relative treatment effects. A total of 107 studies involving 20,501 participants were included. Over a median of 6 months follow-up, telemedicine reduced haemoglobin A1c (HbA1c) by a mean of 0.43% (95% CI: -0.64% to -0.21%). Network meta-analysis showed that all telemedicine strategies were effective in reducing HbA1c significantly compared to usual care except for telecase-management and telementoring, with mean difference ranging from 0.37% and 0.71%. Ranking indicated that teleconsultation was the most effective telemedicine strategy, followed by telecase-management plus telemonitoring, and finally teleeducation plus telecase-management. The review indicates that most telemedicine strategies can be useful, either as an adjunct or to replace usual care, leading to clinically meaningful reduction in HbA1c.
UR - http://www.scopus.com/inward/record.url?scp=85030709071&partnerID=8YFLogxK
U2 - 10.1038/s41598-017-12987-z
DO - 10.1038/s41598-017-12987-z
M3 - Article
C2 - 28978949
AN - SCOPUS:85030709071
SN - 2045-2322
VL - 7
JO - Scientific Reports
JF - Scientific Reports
M1 - 12680
ER -